“…Specific populations included elite athletes [ 43 ], post-bariatric patients [ 44 ], pregnant women [ 45 ], participants with depression [ 82 ], and children with autism [ 27 ], attention deficit hyperactivity disorder (ADHD, [ 28 ]), and obesity [ 29 ]. Finally, 25 studies (37.5%) were conducted in European countries (Austria, France, Germany, Italy, Poland, Scotland, Spain, and the United Kingdom; [ 27 , 29 , 30 , 31 , 32 , 42 , 43 , 45 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ]), 18 (28.1%) in Asia (Australia, Bangladesh, China, India, Jordan, Kuwait, Turkey and the United Arab Emirates; [ 20 , 21 , 28 , 33 , 34 , 35 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 ]), 12 (18.8%) in North America (Canada and United States; [ 18 , 36 ,…”